Comparison of cardiovascular risk calculators in patients with diabetes
Authors:
- Luana Karem RibeiroLRLuana Karem Ribeiro
- Welma Wildes AmorimWAWelma Wildes Amorim
- Igor Thiago Alvin CardosoICIgor Thiago Alvin Cardoso
- Wester Silva VieiraWVWester Silva Vieira
- Clavdia Nicolaevna KocherginCKClavdia Nicolaevna Kochergin
- Danielle Souto de MedeirosDMDanielle Souto de Medeiros
- Daniela Arruda SoaresDSDaniela Arruda Soares
- José Andrade LouzadoJLJosé Andrade Louzado
- Kelle Oliveira SilvaKSKelle Oliveira Silva
- Matheus Lopes CortesMatheus Lopes Cortes
- Sóstenes MistroSMSóstenes Mistro
- Vanessa Moraes BezerraVBVanessa Moraes Bezerra
Open Access
- 1 February 2021
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (2) , 200-206
Abstract
OBJECTIVE: Cardiovascular risk stratification is an important clinical practice to estimate the severity of cardiovascular disease in patients with type 2 diabetes. This study aimed to compare the stratification of global cardiovascular risk with the specific risk stratification for patients with type 2 diabetes, seen at specialized outpatient clinics, and to evaluate possible differences in diagnoses and treatments. METHODS: A total of 122 patients with type 2 diabetes treated at two specialized outpatient clinics, from 2017 to 2019, were studied. The cardiovascular risk stratification calculators, global risk score, Cardiovascular Risk Stratification Calculator, and United Kingdom Prospective Diabetes Study-Risk Engine, were used to calculate the risk of death from cardiovascular disease. The agreement between these calculators was analyzed using the kappa index. The indications for the use of statins and acetylsalicylic acid for the group studied were evaluated according to the Brazilian Diabetes Society Guideline. RESULTS: There was a low degree of agreement among the three risk calculators. The global risk score calculator showed insignificant agreement with the Cardiovascular Risk Stratification Calculator (kappa=0.0816; p=0.0671). There was no agreement between the global risk score calculator and United Kingdom Prospective Diabetes Study-Risk Engine (kappa=-0.099), or between the Cardiovascular Risk Stratification Calculator and United Kingdom Prospective Diabetes Study-Risk Engine (kappa=-0.0095). CONCLUSION: The substantial disagreements among the cardiovascular risk calculators may lead to different diagnoses and may consequently influence therapeutic strategies. The findings herein highlight the need for specific validated cardiovascular risk calculators for patients with DM2 that can reliably estimate risk in these individuals.Keywords
This publication has 15 references indexed in Scilit:
- Sensitivity of FRAMINGHAM, PROCAM and SCORE models in Turkish people with Type 2 diabetes: comparison of three cardiovascular risk calculationsContemporary Nurse, 2015
- Stratifizierung des kardiovaskulären Risikos bei Patienten mit Typ-2-DiabetesDer Diabetologe, 2014
- External Validation of the UKPDS Risk Engine in Incident Type 2 Diabetes: A Need for New Type 2 Diabetes–Specific Risk EquationsDiabetes Care, 2014
- Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?World Journal of Diabetes, 2014
- I Diretriz Brasileira de Prevenção CardiovascularArquivos Brasileiros de Cardiologia, 2013
- Cardiovascular risk assessment scores for people with diabetes: a systematic reviewDiabetologia, 2009
- Is diabetes a coronary risk equivalent? Systematic review and meta‐analysisDiabetic Medicine, 2009
- Framingham, SCORE, and DECODE Risk Equations Do Not Provide Reliable Cardiovascular Risk Estimates in Type 2 DiabetesDiabetes Care, 2007
- Validation of the Framingham Coronary Heart Disease Prediction ScoresJAMA, 2001
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998